DAPDUNE HOUSE SURGERY — All Prescriptions & Medications — Page 6
Practice Code: H81029 | GUILDFORD, GU1 4RP
Showing results 251-300 of 572
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 77 | 5,100 | £357 | +10.3% ▲ | |
| Cefalexin | 76 | 2,826 | £217 | -34.7% ▼ |
| Tolterodine | 74 | 6,048 | £904 | -50.2% ▼ |
| Adapalene and benzoyl peroxide | 74 | 3,690 | £1.6K | +38.6% ▲ |
| Tamoxifen citrate | 73 | 4,296 | £521 | -11.4% ▼ |
| 73 | 1,200 | £1.8K | +122.4% ▲ | |
| Sulfasalazine | 72 | 13.9K | £3.5K | -44.7% ▼ |
| Betahistine hydrochloride | 72 | 7,496 | £279 | -69.8% ▼ |
| Hydrocortisone acetate | 71 | 2,700 | £516 | +7.5% ▲ |
| Zolmitriptan | 70 | 810 | £2.9K | +7.8% ▲ |
| Ready to serve 1.5 kcal/ml milkshake (0913011) | 70 | 458.6K | £2.5K | -50.7% ▼ |
| Haloperidol | 69 | 1,050 | £1.3K | +44.9% ▲ |
| Co-trimoxazole(Trimethoprim/sulfamethoxazole) | 69 | 1,088 | £91 | +71.7% ▲ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 69 | 1,980 | £1.1K | +168.6% ▲ |
| Ready to serve 1.5 kcal/ml juice style (0913011) | 69 | 546.5K | £5.3K | +13.5% ▲ |
| Timolol | 69 | 1,305 | £370 | -22.0% ▼ |
| Esomeprazole | 68 | 4,200 | £474 | -83.2% ▼ |
| Pizotifen malate | 68 | 5,880 | £242 | -17.5% ▼ |
| Metoclopramide hydrochloride | 67 | 3,394 | £134 | -19.1% ▼ |
| Insulin Lispro | 67 | 464 | £3.0K | -12.4% ▼ |
| Darifenacin hydrobromide | 67 | 1,232 | £1.1K | +105.6% ▲ |
| Sodium bicarbonate | 67 | 8,176 | £369 | -27.5% ▼ |
| Tacrolimus | 67 | 2,310 | £1.8K | +24.3% ▲ |
| Carvedilol | 66 | 5,488 | £185 | -41.8% ▼ |
| Lorazepam | 66 | 3,355 | £620 | -53.7% ▼ |
| Benzoyl peroxide and clindamycin phosphate | 66 | 3,180 | £1.3K | -1.6% vs avg |
| 66 | 5,900 | £10.9K | +35.4% ▲ | |
| 66 | 475 | £146 | -68.4% ▼ | |
| 66 | 8,190 | £503 | -69.5% ▼ | |
| Lacidipine | 64 | 3,556 | £290 | -46.4% ▼ |
| Telmisartan | 63 | 3,780 | £900 | +8.7% ▲ |
| Fenofibrate | 63 | 3,248 | £336 | -34.9% ▼ |
| Fentanyl | 63 | 630 | £1.6K | -38.5% ▼ |
| Topiramate | 63 | 7,240 | £1.3K | -64.6% ▼ |
| Typhoid | 63 | 63 | £652 | -30.0% ▼ |
| 63 | 1,000 | £619 | +46.1% ▲ | |
| 63 | 3,140 | £13.9K | +182.3% ▲ | |
| Nystatin | 62 | 2,200 | £1.4K | -38.5% ▼ |
| Bisacodyl | 61 | 4,538 | £3.7K | -53.5% ▼ |
| Ivabradine | 61 | 6,328 | £1.3K | -35.8% ▼ |
| Oxycodone hydrochloride | 61 | 6,165 | £1.4K | -76.2% ▼ |
| Brivaracetam | 61 | 1,344 | £3.1K | +79.3% ▲ |
| Olopatadine | 61 | 475 | £458 | +39.1% ▲ |
| Hepatitis A | 61 | 61 | £1.2K | -19.7% ▼ |
| Ciprofloxacin | 60 | 1,434 | £103 | +50.4% ▲ |
| Alfacalcidol | 60 | 3,600 | £534 | -51.5% ▼ |
| Terbinafine hydrochloride | 60 | 1,695 | £303 | +61.7% ▲ |
| Enalapril maleate | 59 | 3,052 | £84 | -67.2% ▼ |
| Dabigatran etexilate | 59 | 5,644 | £4.5K | +14.0% ▲ |
| Dulaglutide | 59 | 344 | £6.3K | -48.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.